The Genio system, developed by the American company Nyxoah, has been implanted in the first patients in the United States after being officially approved by the U.S. Food and Drug Administration (FDA). This groundbreaking implant aims to help treat obstructive sleep apnea (OSA), offering an alternative to traditional CPAP masks.
Author: Mikolaj Laszkiewicz
Mikolaj Laszkiewicz
An experienced journalist and editor passionate about new technologies, computers, and scientific discoveries. He strives to bring a unique perspective to every topic. A law graduate.